Estimating the cost of Covid-19 antiviral development

A lot of time and resources are being thrown at developing treatments for Covid-19, with governments around the world pledging to spend whatever it takes to find a treatment. Much of the initial expense will fall on biopharma companies, however.

To estimate how much these investigations might cost, Vantage has extracted estimates from EvaluatePharma Vision and looked at historic precedent, for the development of vaccines and antivirals in previous pandemics.